On August 1, 2024, BD sent an urgent Medical Device Correction update regarding the removal of affected BD BACTEC™ MGIT™ 960 PZA Kits. Through internal BD complaint trending and review of internal raw material testing, lots of BD BACTEC™ MGIT™ 960 PZA Kits were identified that may intermittently produce falsely resistant results for pyrazinamide (PZA) during susceptibility testing of Mycobacterium tuberculosis isolates. The current list of affected lots can be found here.